Henry Ford Hospital Medical Journal


We employed radiographic analysis and a numerical scoring system to evaluate bone and joint destruction in 39 patients who received aspirin and nonsteroidal, antiinflammatory drugs or benoxaprofen therapy over a continuous study period of 36 months (mean). Our purpose was to compare the radiological changes in these patients over two observation intervals and to test the reproducibility of the scoring system. Our modified rating system has sufficient intra-rater reliability to provide a statistically adequate, reproducible method for evaluating bone and joint destruction in rheumatoid arthritis.